Zheng Yiwu, Li Zhuoru, Ren Jing, Liu Weidong, Wu Yaqi, Zhao Yibing, Wu Chuanliu
The MOE Key Laboratory of Spectrochemical Analysis and Instrumentation , State Key Laboratory of Physical Chemistry of Solid Surfaces , Collaborative Innovation Center of Chemistry for Energy Materials , Department of Chemistry , College of Chemistry and Chemical Engineering , Xiamen University , Xiamen , 361005 , P.R. China . Email:
Chem Sci. 2017 Apr 1;8(4):2547-2552. doi: 10.1039/c6sc05710a. Epub 2017 Feb 17.
Disulfide-rich peptides are emerging as potential templates for drug design applications. However, the synthesis and reengineering of disulfide-rich peptides are challenging, owing to the complexity of the oxidative folding process involving a number of diverse isomeric structures. Novel disulfide-rich peptide scaffolds that are not besieged by their disulfide isomers are still greatly desired. In this work, we report the design and synthesis of a novel class of artificial disulfide-rich peptide scaffolds with precisely defined disulfide patterns and a minimized number of isomers. In theory, natural peptides with three disulfide bonds have 15 possible isomers. By rationally engineering the thiol-framework of a peptide containing six cysteines with penicillamines and a dithiol amino acid, we demonstrated, for the first time, that the total number of isomers formed after oxidative folding can be decreased to a minimum of two (, from 15 to 2). As fewer isomeric folds are involved in the oxidative folding, the pathway of the folding becomes more concise and the yield of the artificial scaffolds is substantially increased compared to that of its six-cysteine-containing analogue, which makes the artificial disulfide-rich scaffolds (with only 2 predefined isomeric folds) extremely promising for being exploited as structurally complex templates for the design of peptide therapeutics and ligands.
富含二硫键的肽正成为药物设计应用的潜在模板。然而,由于涉及多种异构结构的氧化折叠过程的复杂性,富含二硫键的肽的合成和重新设计具有挑战性。仍然非常需要不受其二硫键异构体困扰的新型富含二硫键的肽支架。在这项工作中,我们报告了一类新型人工富含二硫键的肽支架的设计和合成,其具有精确确定的二硫键模式和最少数量的异构体。理论上,具有三个二硫键的天然肽有15种可能的异构体。通过用青霉胺和二硫醇氨基酸合理改造含有六个半胱氨酸的肽的硫醇骨架,我们首次证明氧化折叠后形成的异构体总数可以减少到最少两种(从15种减少到2种)。由于氧化折叠涉及的异构折叠较少,折叠途径变得更加简洁,与含六个半胱氨酸的类似物相比,人工支架的产率大幅提高,这使得人工富含二硫键的支架(仅具有2种预定义的异构折叠)作为设计肽治疗剂和配体的结构复杂模板极具开发前景。